Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA GLENMARK PHARMA JUBILANT PHARMOVA /
GLENMARK PHARMA
 
P/E (TTM) x -2,647.7 -31.4 - View Chart
P/BV x 1.7 2.9 58.8% View Chart
Dividend Yield % 0.9 0.3 336.9%  

Financials

 JUBILANT PHARMOVA    GLENMARK PHARMA
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-23
GLENMARK PHARMA
Mar-23
JUBILANT PHARMOVA /
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs496487 101.7%   
Low Rs269349 77.0%   
Sales per share (Unadj.) Rs394.4460.4 85.7%  
Earnings per share (Unadj.) Rs-4.113.4 -30.5%  
Cash flow per share (Unadj.) Rs30.735.0 87.6%  
Dividends per share (Unadj.) Rs5.002.50 200.0%  
Avg Dividend yield %1.30.6 218.8%  
Book value per share (Unadj.) Rs338.6335.1 101.0%  
Shares outstanding (eoy) m159.28282.17 56.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.00.9 106.7%   
Avg P/E ratio x-93.831.3 -300.2%  
P/CF ratio (eoy) x12.411.9 104.3%  
Price / Book Value ratio x1.11.2 90.5%  
Dividend payout %-122.718.7 -656.7%   
Avg Mkt Cap Rs m60,873117,953 51.6%   
No. of employees `000NANA-   
Total wages/salary Rs m21,66027,810 77.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m62,817129,901 48.4%  
Other income Rs m3833,168 12.1%   
Total revenues Rs m63,201133,069 47.5%   
Gross profit Rs m7,31715,125 48.4%  
Depreciation Rs m5,5406,113 90.6%   
Interest Rs m1,8823,496 53.8%   
Profit before tax Rs m2788,685 3.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9274,911 18.9%   
Profit after tax Rs m-6493,774 -17.2%  
Gross profit margin %11.611.6 100.0%  
Effective tax rate %333.556.5 589.9%   
Net profit margin %-1.02.9 -35.6%  
BALANCE SHEET DATA
Current assets Rs m37,62498,737 38.1%   
Current liabilities Rs m17,72450,455 35.1%   
Net working cap to sales %31.737.2 85.2%  
Current ratio x2.12.0 108.5%  
Inventory Days Days257 366.1%  
Debtors Days Days56115 48.5%  
Net fixed assets Rs m71,66876,920 93.2%   
Share capital Rs m159282 56.4%   
"Free" reserves Rs m53,77294,281 57.0%   
Net worth Rs m53,93194,563 57.0%   
Long term debt Rs m31,10438,521 80.7%   
Total assets Rs m109,292175,658 62.2%  
Interest coverage x1.13.5 32.9%   
Debt to equity ratio x0.60.4 141.6%  
Sales to assets ratio x0.60.7 77.7%   
Return on assets %1.14.1 27.3%  
Return on equity %-1.24.0 -30.1%  
Return on capital %2.59.2 27.8%  
Exports to sales %00-   
Imports to sales %4.10-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m2,564NA-   
Fx inflow Rs m7,10046,464 15.3%   
Fx outflow Rs m2,56412,712 20.2%   
Net fx Rs m4,53633,751 13.4%   
CASH FLOW
From Operations Rs m6,6076,254 105.6%  
From Investments Rs m-5,444-5,285 103.0%  
From Financial Activity Rs m-1,567-775 202.3%  
Net Cashflow Rs m301325 92.6%  

Share Holding

Indian Promoters % 47.4 46.7 101.6%  
Foreign collaborators % 3.3 0.0 -  
Indian inst/Mut Fund % 23.2 34.7 66.9%  
FIIs % 20.3 23.7 85.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 53.4 92.4%  
Shareholders   86,588 209,931 41.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Jubilant Pharmova vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Jubilant Pharmova vs Glenmark Pharma Share Price Performance

Period Jubilant Pharmova Glenmark Pharma S&P BSE HEALTHCARE
1-Day -0.54% -0.57% 1.18%
1-Month 2.20% 5.16% -0.75%
1-Year 109.28% 112.94% 61.82%
3-Year CAGR -6.79% 27.51% 18.16%
5-Year CAGR -2.78% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the Jubilant Pharmova share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of Jubilant Pharmova hold a 50.7% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Jubilant Pharmova and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, Jubilant Pharmova paid a dividend of Rs 5.0 per share. This amounted to a Dividend Payout ratio of -122.7%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of Jubilant Pharmova, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.